Low ERCC1 expression is a good predictive marker in lung adenocarcinoma patients receiving chemotherapy based on platinum in all TNM stages - a single-center study

Low ERCC1 expression is a good predictive marker in lung adenocarcinoma patients receiving chemotherapy based on platinum in all TNM stages - a single-center study

Abstract Background High ERCC1 expression is thought to be related with resistance to chemotherapy based on platinum. The aim of this study was to present our institutional observations regarding to the association of ERCC1 and overall survival (OS) of the lung adenocarcinoma patients who received c...

Full description

Bibliographic Details
Main Authors: Marina Piljić Burazer, Suzana Mladinov, Antonela Matana, Sendi Kuret, Joško Bezić, Merica Glavina Durdov
Format: Article
Language:English
Published: BMC 2019-09-01
Series:Diagnostic Pathology
Subjects:
Lung adenocarcinoma
ERCC1
Platinum-based chemotherapy
Online Access:http://link.springer.com/article/10.1186/s13000-019-0885-2

Similar Items

Similar Items